Text Size
866 studies found for:    "Osteoporosis"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Completed Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
Conditions: Osteoporosis;   Bone Loss, Age Related;   Postmenopausal Bone Loss;   Postmenopausal Osteoporosis
Intervention: Behavioral: Osteoporosis Choice Decision Aid
2 Completed A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
Conditions: Low Bone Mass;   Low Bone Mineral Density;   Osteoporosis;   Postmenopausal Osteoporosis
Intervention: Procedure: Bone Biopsy
3 Terminated A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.
Conditions: Postmenopausal Osteoporosis;   Osteoporosis
Interventions: Drug: Ronacaleret;   Drug: Teriparatide;   Drug: Alendronate
4 Completed Patient- and Physician-Based Osteoporosis Education
Conditions: Osteoporosis;   Osteoporosis, Postmenopausal
Intervention: Behavioral: Osteoporosis Education
5 Completed A Study for Teriparatide in Severe Osteoporosis
Conditions: Osteoporosis, Postmenopausal;   Osteoporosis
Intervention: Drug: Teriparatide
6 Completed
Has Results 		MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012 AM1)
Conditions: Osteoporosis;   Postmenopausal Osteoporosis
Interventions: Drug: MK-5442;   Drug: Placebo to MK-5442;   Drug: Alendronate Sodium;   Drug: Vitamin D3;   Drug: Calcium carbonate;   Drug: Placebo to Alendronate
7 Unknown † Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
Conditions: Postmenopausal Osteoporosis;   Osteoporosis
Intervention: Drug: synthetic hPTH 1-34
8 Completed
Has Results 		Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
Conditions: Low Bone Mass;   Low Bone Mineral Density;   Males With Osteoporosis;   Osteopenia;   Osteoporosis
Interventions: Drug: 60 mg denosumab;   Other: Placebo
9 Active, not recruiting Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
Conditions: Osteoporosis;   Postmenopausal Osteoporosis
Interventions: Drug: Placebo;   Drug: BA058 80 mcg;   Drug: teriparatide
10 Completed A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis
Condition: Osteoporosis
Interventions: Drug: placebo;   Drug: denosumab
11 Completed Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis
Conditions: Hypogonadism;   Paraplegia;   Bone Density;   Osteoporosis
Intervention: Drug: Testosterone Undeconate (Nebido-R, BAY86-5037)
12 Withdrawn Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)
Conditions: Osteoporosis;   Postmenopausal Osteoporosis
Interventions: Drug: Odanacatib;   Drug: Alendronate;   Other: Placebo (odanacatib);   Dietary Supplement: Cholecalciferol (Vitamin D3);   Dietary Supplement: Calcium carbonate;   Other: Placebo (alendronate)
13 Completed PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)
Conditions: Postmenopause;   Osteoporosis
Intervention: Drug: Parathyroid hormone (PTH) (Preotact)
14 Unknown † Texture Analysis for Postmenopausal Osteoporosis
Conditions: Osteoporosis;   Osteopenia
Intervention: Drug: Alendronate 70mg
15 Recruiting Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
16 Completed Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients.
Conditions: Chronic Obstructive Pulmonary Disease;   Osteoporosis
Intervention:
17 Completed Comparison Study of PTHrP and PTH to Treat Osteoporosis
Condition: Osteoporosis
Interventions: Drug: Parathyroid hormone related protein (1-36);   Drug: Parathyroid hormone related protein(1-36);   Drug: Parathyroid hormone (1-34)
18 Unknown † Strategies to Treat Osteoporosis Following a Fragility Fracture
Conditions: Osteoporosis;   Fragility Fractures
Interventions: Behavioral: Control group;   Behavioral: Minimal Intervention;   Behavioral: Intensive Intervention
19 Active, not recruiting Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis
Conditions: Osteopenia;   Osteoporosis
Intervention: Drug: denosumab
20 Recruiting Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 785;   Drug: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years